Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements Of Cash Flows (Unaudited)

v3.24.1.1.u2
Condensed Consolidated Statements Of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash Flows from Operating Activities:    
Net loss $ (6,485) $ (5,849)
Adjustments to reconcile net loss to net cash and cash equivalents used in operating activities:    
Depreciation 660 149
Recoveries of bad debts (27) (17)
Amortization of debt issuance costs 125 107
Change in fair value of warrants 556 0
Issuance costs for common stock warrants 830 0
Stock-based compensation 113 691
Gain on disposal of fixed assets (156) 0
Changes in operating assets and liabilities:    
Accounts receivable (177) 700
Inventory 133 (1,890)
Prepaid expenses and other current assets (59) 240
Accounts payable and accrued liabilities (1,308) 303
Deferred revenue (143) (92)
Net cash and cash equivalents used in operating activities (5,938) (5,658)
Cash Flows from Investing Activities:    
Purchases of property, plant, and equipment 0 (587)
Proceeds from disposal of property, plant, and equipment 197 0
Net cash and cash equivalents provided by (used in) investing activities 197 (587)
Cash Flows from Financing Activities:    
Proceeds from the sale of common stock and pre-funded warrants, net of fees 2,784 8,503
Proceeds from the sale of warrants, net of fees 3,020 0
Principal payment on term loan (165) 0
Proceeds from the exercise of common stock warrants 8 14
Net cash and cash equivalents provided by financing activities 5,647 8,517
Effect of exchange rate changes (79) 79
(Decrease) increase in cash and cash equivalents (173) 2,351
Cash and cash equivalents, beginning of period 6,566 4,181
Cash and cash equivalents, end of period 6,393 6,532
Supplemental cash flow disclosure:    
Cash paid for interest 494 470
Cash received for interest 2 2
Cash paid (received) for income taxes 8 (14)
Cash paid for operating leases 77 68
Non-cash property, plant and equipment additions acquired under inventory 27 0
Common stock issued upon cashless warrant exercise 1,989 0
Non-cash right-of-use assets obtained in exchange for lease obligation $ 0 $ 464